Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma

This publication has 32 references indexed in Scilit:

• Expression of TRAIL (TNF‐related apoptosis‐inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas
  The Journal of Pathology, 2003
• Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation
  Oncogene, 2003
• Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs
  European Journal Of Cancer, 2002
• Synergistic Induction of Apoptosis by the Combination of TRAIL and Chemotherapy in Chemoresistant Ovarian Cancer Cells
  Gynecologic Oncology, 2001
• Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan
  Cell Death & Differentiation, 2000
• Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma
  Hepatology, 2000
• TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention
  Oncogene, 2000
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract
  Oncogene, 1999
• Identification and characterization of a new member of the TNF family that induces apoptosis
  Immunity, 1995